Literature DB >> 19195541

Body perfusion CT: technique, clinical applications, and advances.

Avinash R Kambadakone1, Dushyant V Sahani.   

Abstract

Perfusion CT has made tremendous progress since its inception and is gradually broadening its applications from the research realm into routine clinical care. This has been particularly noteworthy in the oncological setting, where perfusion CT is emerging as a valuable tool in tissue characterization, risk stratification and monitoring treatment effects especially assessing early response to novel targeted therapies. Recent technological advancements in CT have paved ways to overcome the initial limitations of restricted tissue coverage and radiation dose concerns. In this article, the authors review the basic principles and technique of perfusion CT and discuss its various oncologic and non-oncological clinical applications in body imaging.

Mesh:

Substances:

Year:  2009        PMID: 19195541     DOI: 10.1016/j.rcl.2008.11.003

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  67 in total

Review 1.  Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging.

Authors:  Venkata S Katabathina; Nathalie Lassau; Ivan Pedrosa; Chaan S Ng; Srinivasa R Prasad
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

2.  The role of magnetic resonance imaging in oncology.

Authors:  Concepción González Hernando; Laura Esteban; Teresa Cañas; Enrique Van den Brule; Miguel Pastrana
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

3.  64-row MDCT perfusion of head and neck squamous cell carcinoma: technical feasibility and quantitative analysis of perfusion parameters.

Authors:  Lorenzo Faggioni; Emanuele Neri; Francesca Cerri; Eugenia Picano; Veronica Seccia; Luca Muscatello; Stefano Sellari Franceschini; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2010-07-23       Impact factor: 5.315

4.  CT perfusion in solid-body tumours. Part I: Technical issues.

Authors:  G Petralia; L Preda; G D'Andrea; S Viotti; L Bonello; R De Filippi; M Bellomi
Journal:  Radiol Med       Date:  2010-02-22       Impact factor: 3.469

5.  Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography.

Authors:  R Syha; L Grünwald; T Horger; D Spira; D Ketelsen; W Vogel; C D Claussen; M Horger
Journal:  Eur Radiol       Date:  2013-12-05       Impact factor: 5.315

6.  Effect of pre-enhancement set point on computed tomographic perfusion values in normal liver and metastases to the liver from neuroendocrine tumors.

Authors:  Chaan S Ng; Adam G Chandler; James C Yao; Delise H Herron; Ella F Anderson; Chusilp Charnsangavej; Brian P Hobbs
Journal:  J Comput Assist Tomogr       Date:  2014 Jul-Aug       Impact factor: 1.826

Review 7.  [Oncological imaging for therapy response assessment].

Authors:  J Stattaus
Journal:  Radiologe       Date:  2014-01       Impact factor: 0.635

8.  Reproducibility and variability of very low dose hepatic perfusion CT in metastatic liver disease.

Authors:  Osman Melih Topcuoğlu; Muşturay Karçaaltıncaba; Deniz Akata; Mustafa Nasuh Özmen
Journal:  Diagn Interv Radiol       Date:  2016 Nov-Dec       Impact factor: 2.630

9.  Assessment of prior image induced nonlocal means regularization for low-dose CT reconstruction: Change in anatomy.

Authors:  Hao Zhang; Jianhua Ma; Jing Wang; William Moore; Zhengrong Liang
Journal:  Med Phys       Date:  2017-09       Impact factor: 4.071

10.  [Perfusion computed tomography for diffuse liver diseases].

Authors:  S A Schmidt; M S Juchems
Journal:  Radiologe       Date:  2012-08       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.